Related Experiment Video
Updated: May 13, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Novel Pathogenic Variants in POLR3K Cause POLR3-Related Leukodystrophy
Stefanie Perrier1,2, Julia Macintosh1,2, Agata D Misiaszek3,4
1Department of Neurology and Neurosurgery McGill University, Montréal, Quebec, Canada.
Abstract:
POLR3-related hypomyelinating leukodystrophy (POLR3-HLD) is a rare inherited neurological disorder caused by biallelic pathogenic variants in specific genes encoding subunits of RNA polymerase III (Pol III). Here, we report the third patient worldwide with pathogenic variants in POLR3K and clinical features consistent with POLR3-HLD. The female patient presented with mild intellectual and behavioural disturbances in childhood, as well as growth delay, with brain MRI revealing diffuse hypomyelination and a pattern consistent with POLR3-HLD. In adolescence, she manifested minor motor dysfunction. Next-generation sequencing revealed a paternally inherited missense variant in POLR3K (c.322G>T; p.D108Y) and a maternally inherited large deletion, spanning approximately 17.8 kb from chr16:30,362-48,162. The missense variant is located at the C-terminus position of the protein and is predicted to impair residue interactions and cause steric interference in enzyme conformational changes. The large deletion encompasses the third and last exon of POLR3K, leading to a likely amorphic truncated protein product lacking the final 42 amino acids from the total 108 amino acid-length protein. Studies of RNA-level expression showed a significant reduction in the levels of POLR3K RNA in the patient compared to the control. In considering whether the transcriptional function of Pol III was affected, the expression of several Pol III-transcribed RNAs was measured, where the levels of several distinct tRNAs were significantly reduced in the patient while the expression of other RNA transcripts was not decreased, suggesting that Pol III retains partial function. This study provides further evidence for the association of pathogenic variants in POLR3K with POLR3-HLD, expanding the spectrum of pathogenic variants in genes encoding for Pol III subunits associated with this disease.
Insights
This study details a patient with POLR3-related hypomyelinating leukodystrophy (POLR3-HLD) caused by novel POLR3K gene variants. The findings expand the known genetic causes of this rare neurological disorder.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- POLR3-related hypomyelinating leukodystrophy (POLR3-HLD) is a rare inherited neurological disorder.
- It is caused by pathogenic variants in genes encoding subunits of RNA polymerase III (Pol III).
Purpose of the Study:
- To report the third patient worldwide with pathogenic variants in the POLR3K gene.
- To characterize the clinical features and genetic basis of POLR3-HLD in this patient.
Main Methods:
- Next-generation sequencing was used to identify pathogenic variants in POLR3K.
- RNA-level expression studies were conducted to assess the impact of the variants.
- Brain MRI was performed to evaluate myelination patterns.
Main Results:
- The patient presented with intellectual and behavioral disturbances, growth delay, and minor motor dysfunction.
- Novel pathogenic variants in POLR3K, including a missense variant and a large deletion, were identified.
- Reduced POLR3K RNA levels and decreased expression of specific tRNAs were observed, suggesting partial Pol III function.
Conclusions:
- This case provides further evidence linking pathogenic variants in POLR3K to POLR3-HLD.
- The findings expand the spectrum of genetic causes for this rare leukodystrophy.
- Understanding these variants contributes to the diagnosis and potential therapeutic strategies for POLR3-HLD.
Related Concept Videos
Viral Mutations
Single Nucleotide Polymorphisms-SNPs
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Genome Size and the Evolution of New Genes
Viral Recombination

